l-arginine promotes angio-osteogenesis to enhance oxidative stress-inhibited bone formation by ameliorating mitophagy

• Published in: Journal of orthopaedic translation 2024-05, Vol.46, p.53-64
• Main Authors: Shen, Yang, Wang, Haoming, Xie, Hongwei, Zhang, Jiateng, Ma, Qingliang, Wang, Shiyu, Yuan, Putao, Xue, Hong, Hong, Huaxing, Fan, Shunwu, Xu, Wenbin, Xie, Ziang
• Format: Article
• Language: English
• Subjects: angiogenesis; l-arginine; mitophagy; Original; Osteogenesis
• ISSN: 2214-031X; 2214-0328
• DOI: 10.1016/j.jot.2024.03.003

Osteoporosis is one of the most common bone diseases in middle-aged and elderly populations worldwide. The development of new drugs to treat the disease is a key focus of research. Current treatments for osteoporosis are mainly directed at promoting osteoblasts and inhibiting osteoclasts. However, there is currently no ideal approach for osteoporosis treatment. l-arginine is a semi-essential amino acid involved in a number of cellular processes, including nitric production, protein biosynthesis, and immune responses. We previously reported that l-arginine-derived compounds can play a regulatory role in bone homeostasis. To investigate the specific effect of l-arginine on bone homeostasis. Mildly aged and ovariectomized mouse models were used to study the effects of l-arginine on osteogenesis and angiogenesis, assessed by micro-computed tomography and immunostaining of bone tissue. The effect of l-arginine on osteogenesis, angiogenesis, and adipogenesis was further studied in vitro using osteoblasts obtained from cranial cap bone, endothelial cells, and an adipogenic cell line. Specific methods to assess these processes included lipid staining, cell migration, tube-forming, and wound-healing assays. Protein and mRNA expression was determined for select biomarkers. We found that l-arginine attenuated bone loss and promoted osteogenesis and angiogenesis. l-arginine increased the activity of vascular endothelial cells, whereas it inhibited adipogenesis in vitro. In addition, we found that l-arginine altered the expression of PINK1/Parkin and Bnip3 in the mitochondria of osteoblast-lineage and endothelial cells, thereby promoting mitophagy and protecting cells from ROS. Similarly, l-arginine treatment effectively ameliorated osteoporosis in an ovariectomized mouse model. l-arginine promotes angio-osteogenesis, and inhibits adipogenesis, effects mediated by the PINK1/Parkin- and Bnip3-mediated mitophagy. L-arginine supplementation may be an effective adjunct therapy in the treatment of osteoporosis. [Display omitted] The Translational Potential of this Article:l-arginine supplementation may be an effective adjunct therapy in the treatment of osteoporosis.